190 related articles for article (PubMed ID: 3093887)
1. Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones.
Shaw S; Luce GE; Quinones R; Gress RE; Springer TA; Sanders ME
Nature; 1986 Sep 18-24; 323(6085):262-4. PubMed ID: 3093887
[TBL] [Abstract][Full Text] [Related]
2. The lymphocyte function-associated antigen (LFA)-1 and CD2/LFA-3 pathways of antigen-independent human T cell adhesion.
Shaw S; Luce GE
J Immunol; 1987 Aug; 139(4):1037-45. PubMed ID: 3302041
[TBL] [Abstract][Full Text] [Related]
3. Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation.
Van de Wiel-van Kemenade E; Te Velde AA; De Boer AJ; Weening RS; Fischer A; Borst J; Melief CJ; Figdor CG
Eur J Immunol; 1992 Jun; 22(6):1467-75. PubMed ID: 1376259
[TBL] [Abstract][Full Text] [Related]
4. Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity.
Makgoba MW; Sanders ME; Ginther Luce GE; Gugel EA; Dustin ML; Springer TA; Shaw S
Eur J Immunol; 1988 Apr; 18(4):637-40. PubMed ID: 2896596
[TBL] [Abstract][Full Text] [Related]
5. CTL adhesion and antigen recognition are discrete steps in the human CTL-target cell interaction.
Mentzer SJ; Smith BR; Barbosa JA; Crimmins MA; Herrmann SH; Burakoff SJ
J Immunol; 1987 Mar; 138(5):1325-30. PubMed ID: 3543126
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of cytotoxic T lymphocyte (CTL) clones to inhibition by anti-T3 and anti-T4 (but not anti-LFA-1) monoclonal antibodies varies with the "avidity" of CTL-target interaction.
Shaw S; Goldstein G; Springer TA; Biddison WE
J Immunol; 1985 May; 134(5):3019-26. PubMed ID: 2580011
[TBL] [Abstract][Full Text] [Related]
7. The role of the T cell receptor, CD8, and LFA-1 in different stages of the cytolytic reaction mediated by alloreactive T lymphocyte clones.
Blanchard D; van Els C; Borst J; Carrel S; Boylston A; de Vries JE; Spits H
J Immunol; 1987 Apr; 138(8):2417-21. PubMed ID: 3104466
[TBL] [Abstract][Full Text] [Related]
8. The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3.
Selvaraj P; Plunkett ML; Dustin M; Sanders ME; Shaw S; Springer TA
Nature; 1987 Mar 26-Apr 1; 326(6111):400-3. PubMed ID: 2951597
[TBL] [Abstract][Full Text] [Related]
9. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
Galocha B; López D; López de Castro JA
J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
[TBL] [Abstract][Full Text] [Related]
10. LFA-1, LFA-2, and LFA-3 antigens are involved in CTL-target conjugation.
Krensky AM; Robbins E; Springer TA; Burakoff SJ
J Immunol; 1984 May; 132(5):2180-2. PubMed ID: 6201533
[TBL] [Abstract][Full Text] [Related]
11. Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.
Scott CF; Bolender S; McIntyre GD; Holldack J; Lambert JM; Venkatesh YP; Morimoto C; Ritz J; Schlossman SF
J Immunol; 1989 Jun; 142(11):4105-12. PubMed ID: 2565930
[TBL] [Abstract][Full Text] [Related]
12. Effects of monoclonal antibodies to the alpha and beta chains of the human lymphocyte function-associated (H-LFA-1) antigen on T lymphocyte functions.
Dongworth DW; Gotch FM; Hildreth JE; Morris A; McMichael AJ
Eur J Immunol; 1985 Sep; 15(9):888-92. PubMed ID: 3930261
[TBL] [Abstract][Full Text] [Related]
13. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
Gromkowski SH; Heagy W; Martz E
J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
[TBL] [Abstract][Full Text] [Related]
14. Interaction of CD2 with its ligand, LFA-3, in human T cell proliferation.
Bierer BE; Barbosa J; Herrmann S; Burakoff SJ
J Immunol; 1988 May; 140(10):3358-63. PubMed ID: 2834437
[TBL] [Abstract][Full Text] [Related]
15. Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies.
Leo O; Foo M; Henkart PA; Perez P; Shinohara N; Segal DM; Bluestone JA
J Immunol; 1987 Dec; 139(11):3556-63. PubMed ID: 3316387
[TBL] [Abstract][Full Text] [Related]
16. Membrane glycoprotein p150,95 of human cytotoxic T cell clone is involved in conjugate formation with target cells.
Keizer GD; Borst J; Visser W; Schwarting R; de Vries JE; Figdor CG
J Immunol; 1987 May; 138(10):3130-6. PubMed ID: 3106475
[TBL] [Abstract][Full Text] [Related]
17. Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro.
Böhmig GA; Kovarik J; Holter W; Pohanka E; Zlabinger GJ
J Immunol; 1994 Apr; 152(8):3720-8. PubMed ID: 7511657
[TBL] [Abstract][Full Text] [Related]
18. Anti-T3 antibody both activates and inhibits the cytotoxic activity of human T cell clones.
Hoffman RW; Quinones RR; Shaw S
Behring Inst Mitt; 1985 Aug; (77):30-8. PubMed ID: 3936472
[TBL] [Abstract][Full Text] [Related]
19. T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules.
Schmidt RE; Caulfield JP; Michon J; Hein A; Kamada MM; MacDermott RP; Stevens RL; Ritz J
J Immunol; 1988 Feb; 140(3):991-1002. PubMed ID: 3276787
[TBL] [Abstract][Full Text] [Related]
20. The role of lymphocyte function-associated antigen 1 (LFA-1) in the adherence of T lymphocytes to B lymphocytes.
Mazerolles F; Lumbroso C; Lecomte O; Le Deist F; Fischer A
Eur J Immunol; 1988 Aug; 18(8):1229-34. PubMed ID: 3046949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
